GlassScriptPhysician profile
Larry A Woods
NPI 1417936238
$5,891.71
in general payments reported to CMS, 2019-2025
20 companies · $320 in 2025
The $320 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $765 · 2020: $205 · 2021: $228 · 2022: $683 · 2023: $3,343 · 2024: $349 · 2025: $320.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,644 · Travel and Lodging: $1,368.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,644.12 |
| Travel and Lodging | $1,367.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Angiodynamics, INC. | $2,490.40 | 2022-2023 | Angiovac |
| Novartis Pharmaceuticals Corporation | $643.00 | 2019-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $339.28 | 2019-2025 | Jardiance |
| Merck Sharp & Dohme LLC | $324.50 | 2021-2023 | Verquvo |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $310.84 | 2019-2025 | Lifevest |
| Amgen INC. | $278.72 | 2019-2025 | Repatha, Repatha |
| Astrazeneca Pharmaceuticals LP | $271.00 | 2019-2024 | Farxiga, Brilinta |
| Janssen Pharmaceuticals, INC | $243.53 | 2019-2024 | Xarelto |
| E.R. Squibb & Sons, L.L.C. | $239.98 | 2019-2025 | Eliquis, Camzyos |
| Abiomed | $206.84 | 2019 | |
| Abbott Laboratories | $195.48 | 2019-2025 | Mitraclip |
| Pfizer INC. | $113.45 | 2019-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $46.21 | 2025 | |
| Amarin Pharma, INC. | $40.31 | 2020-2021 | |
| Irhythm Technologies, INC. | $39.40 | 2023 | Zio Xt Patch |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Terumo Medical Corporation | $31.53 | 2023 | Angio-Seal |
| Boston Scientific Corporation | $30.75 | 2022-2025 | Watchman Flx |
| Esperion Therapeutics, INC. | $17.00 | 2020 | |
| Kiniksa Pharmaceuticals International, Plc | $16.24 | 2024 | Arcalyst |
| Inari Medical, INC. | $13.25 | 2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Larry Woods listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.